136 related articles for article (PubMed ID: 36184946)
1. Computational and Crystallographic Analysis of Binding Structures of Inhibitory Compounds for HIV-1 RNase H Activity.
Lu H; Komukai Y; Usami K; Guo Y; Qiao X; Nukaga M; Hoshino T
J Chem Inf Model; 2022 Dec; 62(24):6762-6774. PubMed ID: 36184946
[TBL] [Abstract][Full Text] [Related]
2. Structural and biochemical study on the inhibitory activity of derivatives of 5-nitro-furan-2-carboxylic acid for RNase H function of HIV-1 reverse transcriptase.
Yanagita H; Urano E; Matsumoto K; Ichikawa R; Takaesu Y; Ogata M; Murakami T; Wu H; Chiba J; Komano J; Hoshino T
Bioorg Med Chem; 2011 Jan; 19(2):816-25. PubMed ID: 21193314
[TBL] [Abstract][Full Text] [Related]
3. Derivatives of 5-nitro-furan-2-carboxylic acid carbamoylmethyl ester inhibit RNase H activity associated with HIV-1 reverse transcriptase.
Fuji H; Urano E; Futahashi Y; Hamatake M; Tatsumi J; Hoshino T; Morikawa Y; Yamamoto N; Komano J
J Med Chem; 2009 Mar; 52(5):1380-7. PubMed ID: 19178289
[TBL] [Abstract][Full Text] [Related]
4. Structural modulation study of inhibitory compounds for ribonuclease H activity of human immunodeficiency virus type 1 reverse transcriptase.
Yanagita H; Fudo S; Urano E; Ichikawa R; Ogata M; Yokota M; Murakami T; Wu H; Chiba J; Komano J; Hoshino T
Chem Pharm Bull (Tokyo); 2012; 60(6):764-71. PubMed ID: 22689429
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation and molecular modeling of 2-Hydroxyisoquinoline-1,3-dione analogues as inhibitors of HIV reverse transcriptase associated ribonuclease H and polymerase.
Tang J; Vernekar SKV; Chen YL; Miller L; Huber AD; Myshakina N; Sarafianos SG; Parniak MA; Wang Z
Eur J Med Chem; 2017 Jun; 133():85-96. PubMed ID: 28384548
[TBL] [Abstract][Full Text] [Related]
6. Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase.
Boyer PL; Smith SJ; Zhao XZ; Das K; Gruber K; Arnold E; Burke TR; Hughes SH
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643235
[TBL] [Abstract][Full Text] [Related]
7. A 2-Hydroxyisoquinoline-1,3-Dione Active-Site RNase H Inhibitor Binds in Multiple Modes to HIV-1 Reverse Transcriptase.
Kirby KA; Myshakina NA; Christen MT; Chen YL; Schmidt HA; Huber AD; Xi Z; Kim S; Rao RK; Kramer ST; Yang Q; Singh K; Parniak MA; Wang Z; Ishima R; Sarafianos SG
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760905
[TBL] [Abstract][Full Text] [Related]
8. Sticklac-Derived Natural Compounds Inhibiting RNase H Activity of HIV-1 Reverse Transcriptase.
Ito Y; Lu H; Kitajima M; Ishikawa H; Nakata Y; Iwatani Y; Hoshino T
J Nat Prod; 2023 Nov; 86(11):2487-2495. PubMed ID: 37874155
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of foamy virus reverse transcriptase by human immunodeficiency virus type 1 RNase H inhibitors.
Corona A; Schneider A; Schweimer K; Rösch P; Wöhrl BM; Tramontano E
Antimicrob Agents Chemother; 2014 Jul; 58(7):4086-93. PubMed ID: 24798282
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for the inhibition of RNase H activity of HIV-1 reverse transcriptase by RNase H active site-directed inhibitors.
Su HP; Yan Y; Prasad GS; Smith RF; Daniels CL; Abeywickrema PD; Reid JC; Loughran HM; Kornienko M; Sharma S; Grobler JA; Xu B; Sardana V; Allison TJ; Williams PD; Darke PL; Hazuda DJ; Munshi S
J Virol; 2010 Aug; 84(15):7625-33. PubMed ID: 20484498
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones.
Budihas SR; Gorshkova I; Gaidamakov S; Wamiru A; Bona MK; Parniak MA; Crouch RJ; McMahon JB; Beutler JA; Le Grice SF
Nucleic Acids Res; 2005; 33(4):1249-56. PubMed ID: 15741178
[TBL] [Abstract][Full Text] [Related]
12. 5-Hydroxypyrido[2,3-b]pyrazin-6(5H)-one derivatives as novel dual inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H and integrase.
Sun L; Gao P; Dong G; Zhang X; Cheng X; Ding X; Wang X; Daelemans D; De Clercq E; Pannecouque C; Menéndez-Arias L; Zhan P; Liu X
Eur J Med Chem; 2018 Jul; 155():714-724. PubMed ID: 29940462
[TBL] [Abstract][Full Text] [Related]
13. Structure of a dihydroxycoumarin active-site inhibitor in complex with the RNase H domain of HIV-1 reverse transcriptase and structure-activity analysis of inhibitor analogs.
Himmel DM; Myshakina NS; Ilina T; Van Ry A; Ho WC; Parniak MA; Arnold E
J Mol Biol; 2014 Jul; 426(14):2617-31. PubMed ID: 24840303
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and RDDP functions.
Corona A; Onnis V; Deplano A; Bianco G; Demurtas M; Distinto S; Cheng YC; Alcaro S; Esposito F; Tramontano E
Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28859311
[TBL] [Abstract][Full Text] [Related]
15. Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097.
Das K; Sarafianos SG; Clark AD; Boyer PL; Hughes SH; Arnold E
J Mol Biol; 2007 Jan; 365(1):77-89. PubMed ID: 17056061
[TBL] [Abstract][Full Text] [Related]
16. Cutting into the Substrate Dominance: Pharmacophore and Structure-Based Approaches toward Inhibiting Human Immunodeficiency Virus Reverse Transcriptase-Associated Ribonuclease H.
Wang L; Sarafianos SG; Wang Z
Acc Chem Res; 2020 Jan; 53(1):218-230. PubMed ID: 31880912
[TBL] [Abstract][Full Text] [Related]
17. Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors.
Corona A; Desantis J; Massari S; Distinto S; Masaoka T; Sabatini S; Esposito F; Manfroni G; Maccioni E; Cecchetti V; Pannecouque C; Le Grice SF; Tramontano E; Tabarrini O
ChemMedChem; 2016 Aug; 11(16):1709-20. PubMed ID: 26990134
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of Tyr-501 of HIV-1 reverse transcriptase. Effects on ribonuclease H activity and inhibition of this activity by N-acylhydrazones.
Arion D; Sluis-Cremer N; Min KL; Abram ME; Fletcher RS; Parniak MA
J Biol Chem; 2002 Jan; 277(2):1370-4. PubMed ID: 11684697
[TBL] [Abstract][Full Text] [Related]
19. 6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity.
Wang L; Tang J; Huber AD; Casey MC; Kirby KA; Wilson DJ; Kankanala J; Xie J; Parniak MA; Sarafianos SG; Wang Z
Eur J Med Chem; 2018 Aug; 156():652-665. PubMed ID: 30031976
[TBL] [Abstract][Full Text] [Related]
20. Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activities.
Shaw-Reid CA; Feuston B; Munshi V; Getty K; Krueger J; Hazuda DJ; Parniak MA; Miller MD; Lewis D
Biochemistry; 2005 Feb; 44(5):1595-606. PubMed ID: 15683243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
